摘要
目的分析磁共振成像(MRI)检查对乳腺导管原位癌(DCIS)及浸润性导管癌(IDC)的鉴别诊断价值。方法回顾性收集2018年8月至2020年8月于我院接受诊疗的150例乳腺癌患者临床资料,经手术病理证实后,其中81例IDC患者,69例单纯DCIS患者,所有患者术前均接受MRI,分析MRI影像学表现及鉴别诊断结果。结果DCIS患者非肿块样强化发生率明显高于IDC患者而肿块样强化发生率明显低于IDC患者(P<0.05)。MRI显示,非肿块样强化DCIS与IDC患者病灶分布与内部强化特征对比有统计学差异(P<0.05)。肿块样强化DCIS与IDC患者病灶边缘情况与内部强化特征对比有统计学差异(P<0.05)。结论MRI检查可较为清晰地区别DCIS与IDC患者的病灶特征,在DCIS与IDC的临床鉴别中具有一定的诊断价值。
Objective To analyze the value of magnetic resonance imaging(MRI)in the differential diagnosis of breast ductal carcinoma in situ(DCIS)and invasive ductal carcinoma(IDC).Methods The clinical data of 150 breast cancer patients diagnosed and treated in the hospital from August 2018 to August 2020 were retrospectively collected.Operation and pathology confirmed 81 patients with IDC and 69 patients with simple DCIS.All patients received MRI examination before operation.MRI findings and differential diagnosis results were analyzed.Results The incidence of non-mass-like enhancement in patients with DCIS was significantly higher than that in patients with IDC(P<0.05).MRI showed that there were statistically significant differences in lesion distribution and internal enhancement characteristics of patients with non-mass-like enhancement in DCIS group and IDC group(P<0.05).There were statistically significant differences in marginal condition and internal enhancement characteristics of patients with mass-like enhancement in DCIS group and IDC group(P<0.05).Conclusion MRI can clearly distinguish DCIS from IDC.Therefore,it has certain value in the differential diagnosis of DCIS and IDC.
作者
赵雪
朱晓龙
赵茹
ZHAO Xue;ZHU Xiao-long;ZHAO Ru(Department of Medical Imaging,Beijing Huairou Hospital,Beijing 101400,China;Department of Medical Imaging,the First Affiliated Hospital of Hebei North University,Zhangjiakou 075000,Hebei Province,China)
出处
《中国CT和MRI杂志》
2022年第8期105-107,共3页
Chinese Journal of CT and MRI
关键词
MRI
乳腺导管原位癌
浸润性导管癌
鉴别诊断
MRI
Ductal Carcinoma in Situ
Invasive Ductal Carcinoma
Differential Diagnosis
